Skip to Main Content

Author Details

Freekje van Asten
National Eye Institute, National Institutes of Health.
2013
31
17
PMIDPaper TitleJournal TitlePublished Year
37398472QTL mapping of human retina DNA methylation identifies 87 gene-epigenome interactions in age-related macular degeneration.Res Sq2023
34643793Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol2022
32285590Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.Alzheimers Dement2020
32087877Reply.Ophthalmology2020
32348832Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.Ophthalmology2020
32320661Genome-wide Profiling Identifies DNA Methylation Signatures of Aging in Rod Photoreceptors Associated with Alterations in Energy Metabolism.Cell Rep2020
30318723Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.Acta Ophthalmol2019
30067605ADALIMUMAB THERAPY FOR REFRACTORY BIRDSHOT CHORIORETINOPATHY.Retina2019
30142373Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.Ophthalmology2019
31358387No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.Ophthalmology2019
31048908Age-related changes of the retinal microvasculature.PLoS One2019
29096998A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.Ophthalmology2018
30188024Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.Acta Ophthalmol2018
29852030Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration.JAMA Ophthalmol2018
30060980Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.Ophthalmology2018
30379920Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema.PLoS One2018
29675301Deep learning approach for the detection and quantification of intraretinal cystoid fluid in multivendor optical coherence tomography.Biomed Opt Express2018
29772018The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective.PLoS One2018
29439358Improvement in activities of daily living after visual training in patients with homonymous visual field defects using Goal Attainment Scaling.Restor Neurol Neurosci2018
29224928Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration.Ophthalmology2018
27350361Switching to aflibercept in patients with neovascular age-related macular degeneration not responding to bevacizumab: a pilot study.Acta Ophthalmol2017
28437528Automated Staging of Age-Related Macular Degeneration Using Optical Coherence Tomography.Invest Ophthalmol Vis Sci2017
27379011Visual Rehabilitation in Chronic Cerebral Blindness: A Randomized Controlled Crossover Study.Front Neurol2016
26426212A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.Pharmacogenet Genomics2016
27892514GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration.Sci Rep2016
25488348A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.Acta Ophthalmol2015
25901838ARE INTRAVITREAL INJECTIONS WITH ULTRATHIN 33-G NEEDLES LESS PAINFUL THAN THE COMMONLY USED 30-G NEEDLES?Retina2015
24365177Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.Ophthalmology2014
25393287Zinc supplementation inhibits complement activation in age-related macular degeneration.PLoS One2014
25157998Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration.Ophthalmic Epidemiol2014
23722303αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer.Int J Biol Markers2013
  • 1 - 31 of 31

Recommended Authors

Eye Clinic, Cantonal Hospital of Lucerne
Career Start Year 2014
Number of shared co-authors 1
University of Washington
Career Start Year 2014
Number of shared co-authors 11
Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2012
Number of shared co-authors 1
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 2
University Hospital Montpellier
Career Start Year 2009
Number of shared co-authors 7
University of Manchester
Career Start Year 2009
Number of shared co-authors 8
Singapore Eye Research Institute
Career Start Year 2007
Number of shared co-authors 2
Erasmus Medical Center
Career Start Year 2006
Number of shared co-authors 14
Universitats-Augenklinik Mannheim
Career Start Year 2006
Number of shared co-authors 7
University Hospital Zurich and University of Zurich
Career Start Year 2006
Number of shared co-authors 5
The University of Sydney Save Sight Institute
Career Start Year 2005
Number of shared co-authors 2
NIHR Moorfields Biomedical Research Centre
Career Start Year 2003
Number of shared co-authors 8
Queen's University Belfast
Career Start Year 2003
Number of shared co-authors 10
Singapore Eye Research Institute
Career Start Year 2002
Number of shared co-authors 6
Duke University Medical Center
Career Start Year 2002
Number of shared co-authors 9
University of Manchester
Career Start Year 2001
Number of shared co-authors 4
Novartis Pharma AG
Career Start Year 2001
Number of shared co-authors 5
Hull and East Yorkshire Hospital, Hull and East Yorkshire NHS Trust
Career Start Year 2000
Number of shared co-authors 4
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 5
Universite de Poitiers, INSERM 4 Department of Ophthalmology
Career Start Year 2000
Number of shared co-authors 5
Queen's University Belfast
Career Start Year 1999
Number of shared co-authors 10
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Career Start Year 1999
Number of shared co-authors 13
The University of Sydney Save Sight Institute
Career Start Year 1998
Number of shared co-authors 3
Bristol Eye Hospital
Career Start Year 1997
Number of shared co-authors 10
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 14
Erasmus University Medical Center
Career Start Year 1994
Number of shared co-authors 14
University of Bonn
Career Start Year 1987
Number of shared co-authors 19
The University of Sydney Save Sight Institute
Career Start Year 1987
Number of shared co-authors 9
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 7
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1979
Number of shared co-authors 7

Collaborators

Radboud University Medical Center
Co-authored papers 17
National Eye Institute, National Institutes of Health
Co-authored papers 9
National Eye Institute, National Institutes of Health
Co-authored papers 9
The EMMES Corporation
Co-authored papers 7
Division of Epidemiology and Clinical Applications, National Eye Institute
Co-authored papers 7
National Eye Institute, National Institutes of Health
Co-authored papers 6
National Eye Institute, National Institutes of Health
Co-authored papers 5
Casey Eye Institute, Oregon Health & Science University
Co-authored papers 3
The University of Melbourne
Co-authored papers 2
Royal Victorian Eye and Ear Hospital
Co-authored papers 2
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Co-authored papers 2
National Eye Institute
Co-authored papers 2
Radboud University Medical Center
Co-authored papers 2
University of Wisconsin-Madison School of Medicine and Public Health
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Cancer Center Amsterdam
Co-authored papers 1
Radboud University, Nijmegen Medical Centre
Co-authored papers 1
NIH/National Institute of Ageing
Co-authored papers 1
Co-authored papers 1
Erasmus Medical Center
Co-authored papers 1
Co-authored papers 1
Unit on Clinical Investigation of Retinal Disease, National Eye Institute
Co-authored papers 1
Doheny Eye Institute, University of California Los Angeles
Co-authored papers 1
Co-authored papers 1
University of Washington, USA [2] Seattle Children's Hospital
Co-authored papers 1
Regeneron Pharmaceuticals Inc.
Co-authored papers 1
Radboud University Medical Centre
Co-authored papers 1
Co-authored papers 1
National Eye Institute, National Institutes of Health
Co-authored papers 1